West Virginia has reinforced its groundbreaking 2019 law forbidding what providers say is pharmacy benefit manager discrimination against 340B covered entities.
An amendment passed in March that took effect June 10 clarifies that PBMs or other third-party payers may not require a drug claim “to include a modifier or be processed or resubmitted to indicate that the drug is a 340B drug.”
A new West Virginia law clarifies that PBMs or other third-party payers may not require a drug claim “to include a modifier or be processed or resubmitted to indicate that the drug is a 340B drug.”
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
